论文部分内容阅读
人血浆是广泛应用的多种治疗蛋白的来源,存在着血源性病毒传播的潜在危险。近十几年来人们高度重视血浆制品的安全性,目前采取的多种控制病毒传播的策略,并在不断研究和使用的新技术,已大大提高了血浆制品的安全性,但尚存在对物理和化学处理方法有很强抗力的病毒和突发新的病毒
Human plasma is a source of a wide variety of therapeutic proteins widely used and poses the potential risk of transmission of blood-borne viruses. In recent decades, people attach great importance to the safety of plasma products. Currently, a number of strategies for virus transmission control and the continuous research and application of new technologies have greatly increased the safety of plasma products. However, Chemical treatment has a strong resistance to the virus and a burst of new viruses